- Headquarters
- Copenhagen
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- iobiotech.com
- Total Funding
- $223.1M
- Last Round
- $75.0M Venture RoundAug 2023
- Rounds
- 2
About
IO Biotech is a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines based on its proprietary T-win® platform. Founded in 2015 and headquartered in Copenhagen, Denmark—with US headquarters in New York—IO Biotech's T-win technology is designed to activate T cells to target both tumor cells and immune-suppressive cells in the tumor microenvironment simultaneously. IO Biotech's lead cancer vaccine candidate, Cylembio (formerly IO102-IO103), has advanced into clinical trials, with Phase 1/2 data published in Nature Communications demonstrating long-term clinical and immunological outcomes in first-line metastatic melanoma in combination with PD-1 blockade. The company's pipeline includes additional candidates targeting Arginase 1 (IO112) and TGF-β expressing cells (IO170). IO Biotech is a publicly traded company (Nasdaq: IOBT).
Summary
IO Biotech is a Biotech company based in Copenhagen, United States, founded in 2015. It has raised $223.1M in total across 2 rounds, most recently a $75.0M Venture Round round in Aug 2023. Investors include HBM Healthcare Investments, European Investment Bank and Vivo Capital.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2024
Sign up to see all 3 rounds
Series B through Debt Financing — per-round amounts, valuations, and who invested in each round.
Investors
HBM Healthcare Investments
2 rounds
European Investment Bank
1 round
Vivo Capital
2 rounds
Samsara BioCapital
2 rounds
PFM Health Sciences
2 rounds
Sunstone Life Science Ventures
2 rounds
Lundbeckfonden BioCapital
1 round
Armistice Capital
1 round
Marshall Wace
1 round
Novo Holdings A/S
1 round
Pivotal Life Sciences
1 round
Logos Capital
1 round
The Red Hook Fund LP
1 round
Novo Seeds
1 round
Kurma Partners
1 round
Avoro Ventures
1 round
RA Capital Management
1 round
Idinvest
1 round
Soleus Capital
1 round
EIR Ventures
1 round
Serrado Capital
1 round
Similar Companies
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
Clinical-stage biopharmaceutical company founded in 2015 developing best-in-class cancer therapeu...
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/io-biotech"><img src="https://indexed.vc/api/badge/company/io-biotech" alt="IO Biotech on Indexed.vc" width="260" height="76" /></a>